Show simple item record

Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis

dc.contributor.authorBernstein, Elana J.
dc.contributor.authorJaafar, Sara
dc.contributor.authorAssassi, Shervin
dc.contributor.authorDomsic, Robyn T.
dc.contributor.authorFrech, Tracy M.
dc.contributor.authorGordon, Jessica K.
dc.contributor.authorBroderick, Rachel J.
dc.contributor.authorHant, Faye N.
dc.contributor.authorHinchcliff, Monique E.
dc.contributor.authorShah, Ami A.
dc.contributor.authorShanmugam, Victoria K.
dc.contributor.authorSteen, Virginia D.
dc.contributor.authorKhanna, Dinesh
dc.date.accessioned2020-11-04T15:59:51Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-11-04T15:59:51Z
dc.date.issued2020-11
dc.identifier.citationBernstein, Elana J.; Jaafar, Sara; Assassi, Shervin; Domsic, Robyn T.; Frech, Tracy M.; Gordon, Jessica K.; Broderick, Rachel J.; Hant, Faye N.; Hinchcliff, Monique E.; Shah, Ami A.; Shanmugam, Victoria K.; Steen, Virginia D.; Khanna, Dinesh (2020). "Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis." Arthritis & Rheumatology (11): 1892-1896.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/163424
dc.publisherWiley Periodicals, Inc.
dc.titlePerformance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163424/2/art41415.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163424/1/art41415_am.pdfen_US
dc.identifier.doi10.1002/art.41415
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceSteen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 2007; 66: 940 – 4.
dc.identifier.citedreferenceSteen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994; 37: 1283 – 9.
dc.identifier.citedreferenceTashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma‐related interstitial lung disease (SLS II): a randomised controlled, double‐blind, parallel group trial. Lancet Respir Med 2016; 4: 708 – 19.
dc.identifier.citedreferenceSuliman YA, Dobrota R, Huscher D, Nguyen‐Kim TD, Maurer B, Jordan S, et al. Pulmonary function tests: high rate of false‐negative results in the early detection and screening of scleroderma‐related interstitial lung disease. Arthritis Rheumatol 2015; 67: 3256 – 61.
dc.identifier.citedreferenceTyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809 – 15.
dc.identifier.citedreferenceHoffmann‐Vold AM, Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am J Respir Crit Care Med 2019; 200: 1258 – 66.
dc.identifier.citedreferenceGrimes DA, Schulz KF. Uses and abuses of screening tests [review]. Lancet 2002; 359: 881 – 4.
dc.identifier.citedreferenceAmerican Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277 – 304.
dc.identifier.citedreferenceTravis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733 – 48.
dc.identifier.citedreferenceJones RS, Meade F. A theoretical and experimental analysis of anomalies in the estimation of pulmonary diffusing capacity by the single breath method. Q J Exp Physiol Cogn Med Sci 1961; 46: 131 – 43.
dc.identifier.citedreferenceMacintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single‐breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720 – 35.
dc.identifier.citedreferenceWanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511 – 22.
dc.identifier.citedreferenceVan den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737 – 47.
dc.identifier.citedreferenceShowalter K, Hoffmann A, Rouleau G, Aaby D, Lee J, Richardson C, et al. Performance of forced vital capacity and lung diffusion cutpoints for associated radiographic interstitial lung disease in systemic sclerosis. J Rheumatol 2018; 45: 1572 – 6.
dc.identifier.citedreferenceBernstein EJ, Khanna D, Lederer DJ. Screening high‐resolution computed tomography of the chest to detect interstitial lung disease in systemic sclerosis: a global survey of rheumatologists. Arthritis Rheumatol 2018; 70: 971 – 2.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.